OpenBind’s first data and model release marks a milestone for AI enabled drug discovery

The UK-led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset and predictive AI model, a groundbreaking step toward accelerating the discovery of new medicines using artificial intelligence.

This post was originally published on this site